Profile data is unavailable for this security.
About the company
Prenetics Global Ltd is a company mainly engaged in the diagnostics and genetic testing business. The Company operates its business through two segments. The Diagnostics segment is engaged in the provision of COVID-19 testing services and operation testing laboratories. The Segment is also engaged in the development of health monitoring systems. The Prevention segment is engaged in the provision of genetics testing services to individuals and corporate entities.
- Revenue in USD (TTM)21.74m
- Net income in USD-54.35m
- Incorporated--
- Employees320.00
- LocationPrenetics Global Ltd7/F, K11 Atelier, 728 King's Road 000000Hong KongHKG
- Phone+852 22109588
- Websitehttps://ir.prenetics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology Institute Inc | 342.71m | -59.65m | 36.79m | 800.00 | -- | 0.8893 | -- | 0.1073 | -0.8066 | -0.8066 | 4.63 | 0.5557 | 1.56 | 26.16 | 6.55 | 428,391.30 | -33.23 | -- | -40.16 | -- | 16.76 | 19.54 | -21.29 | -9.99 | 2.83 | -7.94 | 0.6816 | -- | 28.42 | 23.43 | -99,919.12 | -- | 45.68 | -- |
| CRYO-CELL International, Inc. | 31.37m | -9.73m | 66.62m | 82.00 | -- | -- | -- | 2.12 | -1.18 | -1.18 | 3.77 | -1.25 | 0.4908 | 10.31 | 4.74 | 382,579.60 | -15.23 | 0.4686 | -21.73 | 0.7099 | 72.79 | 70.09 | -31.02 | 0.8133 | 0.449 | 5.93 | -- | -- | 3.32 | 1.41 | -443.57 | -- | 60.30 | -- |
| Prenetics Global Ltd | 21.74m | -54.35m | 73.18m | 320.00 | -- | 0.3543 | -- | 3.37 | -4.85 | -5.60 | 1.93 | 16.91 | 0.0768 | 3.37 | 0.9505 | 67,945.84 | -19.92 | -- | -24.55 | -- | 40.61 | -- | -259.40 | -- | 2.29 | -5.88 | 0.0112 | -- | 65.17 | -- | 75.91 | -- | -- | -- |
| Burning Rock Biotech Ltd (ADR) | 71.88m | -81.47m | 73.35m | 786.00 | -- | 0.7399 | -- | 1.02 | -64.81 | -64.81 | 21.58 | 9.66 | 0.4334 | 1.93 | 3.13 | 91,454.42 | -49.12 | -37.09 | -65.97 | -45.29 | 67.27 | 70.02 | -113.34 | -123.88 | 3.05 | -- | 0.00 | -- | -4.58 | 20.81 | 32.69 | -- | -17.61 | -- |
| Cardiff Lexington Corp | 11.65m | 2.36m | 91.14m | 10.00 | 0.4311 | -- | 38.23 | 7.82 | 16.24 | 11.60 | 10.18 | 0.6702 | 0.6319 | -- | 1.05 | 1,165,444.00 | 16.04 | -- | 52.14 | -- | 69.75 | 62.01 | 25.39 | -- | -- | 2.66 | 0.5106 | -- | -- | 39.71 | -- | -- | -- | -- |
| ProPhase Labs Inc | 28.72m | -23.60m | 98.25m | 113.00 | -- | 2.07 | -- | 3.42 | -1.34 | -1.34 | 1.64 | 2.49 | 0.3098 | 5.81 | 0.7872 | 254,115.00 | -25.45 | 0.9106 | -33.00 | 1.12 | 18.41 | 50.32 | -82.18 | 0.9325 | 1.73 | -20.42 | 0.1953 | 665.78 | -63.81 | 27.59 | -190.90 | -- | 86.46 | -- |
Data as of May 30 2024. Currency figures normalised to Prenetics Global Ltd's reporting currency: US Dollar USD
13.04%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Eastspring Investments (Singapore) Ltd.as of 31 Mar 2024 | 684.82k | 6.45% |
| Pacific Alliance Investment Management (HK) Ltd.as of 27 Nov 2023 | 375.29k | 3.53% |
| Nomura Securities Co., Ltd. (Private Banking)as of 31 Mar 2024 | 322.95k | 3.04% |
| UBS Securities LLCas of 31 Mar 2024 | 1.30k | 0.01% |
| Securities America Advisors, Inc.as of 31 Mar 2024 | 450.00 | 0.00% |
| Aspire Private Capital LLCas of 31 Mar 2024 | 114.00 | 0.00% |
| BofA Securities, Inc.as of 31 Mar 2024 | 111.00 | 0.00% |
| Wolverine Asset Management LLCas of 31 Mar 2024 | 1.00 | 0.00% |
| Lumyna Investments Ltd.as of 30 Sep 2022 | 0.00 | 0.00% |
More ▼
Data from 30 Sep 2022 - 31 Mar 2024Source: FactSet Research Systems Inc.
